Table 3:

Univariate analysis of overall survival

	Hazard ratio	95% confidence limits	p-value
Age ≥60 vs <60	2.4	1.8-3.1	<0.0001
KPS 80 vs 90-100	1.5	1.2-2.1	0.0008
Favorable vs adverse cytogenetics	0.3	0.2-0.6	0.0004
Intermediate vs adverse cytogenetics	0.5	0.4-0.7	<0.0001
HCT comorbidity index ≥3 vs 0-2	1.4	1.1- 1.9	0.003
Low intensity vs intensive chemotherapy	3.3	2.4-4.5	<0.0001
No chemotherapy vs intensive chemotherapy	8.5	5.3-13.7	<0.0001
HCT- Yes vs No	0.3	0.2-0.4	<0.0001

HCT-Hematopoietic cell transplant, KPS- Karnofsky performance scale